Multiple GPCRs have been extensively associated with cancer, for example, the thyrotropin receptor in thyroid adenomas [79], estrogen receptors GPER1 and GPR30 in breast cancer [80,81], and gonadotropin-releasing hormone receptor GnRH in prostate cancer. Here, GPER1 is linked to breast carcinoma.